Targeted Health Coaching to Improve Physical Activity Post-Structured Cardiac Rehabilitation
NCT ID: NCT05773287
Last Updated: 2025-06-17
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
13 participants
INTERVENTIONAL
2023-09-26
2024-06-26
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Stress Management and Biomarkers of Risk in Cardiac Rehabilitation
NCT00981253
Exercise Training Adherence After Cardiac Rehabilitation in Coronary Heart Disease Patients
NCT01246570
Cardiac Rehabilitation and Sedentary Behavior
NCT03200756
Effects of Cardiac Rehabilitation (CR) on Functional Capacity and Cardiovascular Risk Factors
NCT02575976
Prospective Aerobic Reconditioning Intervention Study
NCT01113840
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Targeted Health Coaching Group
Targeted Health Coaching Group
Participants in the THC group will receive an exercise prescription (steps/day) based on their last cardiac rehabilitation session exercise prescription. Participants will be provided a Garmin wearable device to track steps/day. Additionally, participants will partake in 6 virtual or in-person health coaching sessions lasting approximately 30-60 minutes in duration. These sessions will take place approximately every other week during the 3-month intervention period.
Standard Care Group
Standard Care Group
Participants in the SC group will receive an exercise prescription (steps/day) based on their last cardiac rehabilitation session exercise prescription. Participants will be provided a Garmin wearable device to track steps/day. Additionally, participants will be provided with a single virtual or in-person education session, lasting approximately 30 minutes, at the beginning of the 3-month intervention period.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Targeted Health Coaching Group
Participants in the THC group will receive an exercise prescription (steps/day) based on their last cardiac rehabilitation session exercise prescription. Participants will be provided a Garmin wearable device to track steps/day. Additionally, participants will partake in 6 virtual or in-person health coaching sessions lasting approximately 30-60 minutes in duration. These sessions will take place approximately every other week during the 3-month intervention period.
Standard Care Group
Participants in the SC group will receive an exercise prescription (steps/day) based on their last cardiac rehabilitation session exercise prescription. Participants will be provided a Garmin wearable device to track steps/day. Additionally, participants will be provided with a single virtual or in-person education session, lasting approximately 30 minutes, at the beginning of the 3-month intervention period.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Must be able to read and speak English well enough to provide informed consent and understand instructions
* Age ≥60 years
* Diagnosed with coronary heart disease
* Of adequate clinical stability to allow study participation
* Own a smartphone device for application download
Exclusion Criteria
* Medical procedure scheduled within the 3-month study period that may limit physical activity (i.e., joint replacement)
* Decompensated heart failure
* Heart failure - New York Heart Association class IV
* Severe pulmonary hypertension
* End-stage renal disease
* Cardiac transplantation
* Impairment from stroke, injury, or other medical condition that would prevent participation in the intervention
* Dementia that would prevent participation in the intervention and following study protocols
* Any other illnesses that, in the opinion of the local clinician, would negatively impact or mitigate participation in and completion of the protocol
* Psychiatric illness (self-report and screening)
* Hospitalization for any psychiatric condition within one year (self-report)
* Integrative Health Coaching Mental Health Screening Questionnaire score \>4 (screening)
* Participation in an inpatient substance abuse rehabilitation program within one year
60 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Institute on Aging (NIA)
NIH
Duke University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
William E. Kraus, MD
Role: PRINCIPAL_INVESTIGATOR
Duke University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Duke Center For Living
Durham, North Carolina, United States
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol and Statistical Analysis Plan
Document Type: Informed Consent Form
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Pro00112929
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.